Eculizumab for Hyperhemolysis in Sickle Cell Disease: Key Insights From a Challenging Case
Hyperhemolysis (HS) is a rare but potentially fatal complication after blood transfusion in patients with sickle cell disease. This is indicated by a decrease in hemoglobin levels following the transfusion compared with pretransfusion levels. Management is complicated by difficulty arriving at a dia...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American College of Physicians
2024-12-01
|
| Series: | Annals of Internal Medicine: Clinical Cases |
| Online Access: | https://www.acpjournals.org/doi/10.7326/aimcc.2024.0424 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|